By Ben Hirschler LONDON (Reuters) - Drugmakers sprinting to develop Ebola vaccines face a series of technical hurdles if they are to get millions of doses ready for use next year -- even assuming clinical trials are successful. The challenges include finding sufficient sterile capacity for filling and packaging finished vials, getting fast quality approvals from regulators, and building a supply chain in Africa for products that must be stored at minus 80 degrees Celsius. ...
via Health News Headlines - Yahoo News http://ift.tt/1t9CL4O
No comments:
Post a Comment